AngioDynamics sees double with Navilyst buy
This article was originally published in Clinica
Executive Summary
AngioDynamics is anticipating doubling its share of the global vascular access market with the proposed acquisition of privately-held Navilyst Medical in a cash-and-stock deal worth approximately $372m.